Blood Cancer Journal (Oct 2023)
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
- Preetesh Jain,
- Krystle Nomie,
- Nikita Kotlov,
- VitaIy Segodin,
- Holly Hill,
- Chi Young Ok,
- Ahmed Fetooh,
- Rashmi Kanagal-Shamanna,
- Francisco Vega,
- Alexander Bagaev,
- Nathan Fowler,
- Christopher R. Flowers,
- Michael Wang
Affiliations
- Preetesh Jain
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- Krystle Nomie
- BostonGene Corporation
- Nikita Kotlov
- BostonGene Corporation
- VitaIy Segodin
- BostonGene Corporation
- Holly Hill
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- Chi Young Ok
- Department of Hematopathology at The University of Texas MD Anderson Cancer Center
- Ahmed Fetooh
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- Rashmi Kanagal-Shamanna
- Department of Hematopathology at The University of Texas MD Anderson Cancer Center
- Francisco Vega
- Department of Hematopathology at The University of Texas MD Anderson Cancer Center
- Alexander Bagaev
- BostonGene Corporation
- Nathan Fowler
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- Christopher R. Flowers
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- Michael Wang
- Department of Lymphoma and Myeloma from The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-023-00927-2
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 5
Abstract
No abstracts available.
